我们能做到多小?部分膀胱放射治疗和近距离治疗

IF 2.6 3区 医学 Q3 ONCOLOGY Seminars in Radiation Oncology Pub Date : 2023-01-01 DOI:10.1016/j.semradonc.2022.10.010
Jenna M. Kahn , Geert A.H.J. Smits , Bernard J. Oosterveld , Elzbieta M. van der Steen-Banasik
{"title":"我们能做到多小?部分膀胱放射治疗和近距离治疗","authors":"Jenna M. Kahn ,&nbsp;Geert A.H.J. Smits ,&nbsp;Bernard J. Oosterveld ,&nbsp;Elzbieta M. van der Steen-Banasik","doi":"10.1016/j.semradonc.2022.10.010","DOIUrl":null,"url":null,"abstract":"<div><p><span>Organ preservation for muscle-invasive </span>bladder<span> cancer (MIBC) may use trimodality therapy. This includes transurethral resection<span><span><span><span> followed by radiation therapy<span><span>. Radiosensitization has become one of the </span>standard of care<span> approaches for MIBC with high rates of local disease control and overall survival. The goal of organ preservation is to treat MIBC while preserving a well-functioning natural bladder. Debate remains over the best way to optimize radiation therapy in bladder cancer. In MIBC the role of </span></span></span>partial cystectomy has been utilized in smaller solitary tumors with adequate local control and good </span>urinary<span> function. As radiation therapy techniques improve and modernize, smaller radiation volumes to a partial bladder may play an increasing role as we utilize imaging techniques coupled with adaptive </span></span>radiation therapy planning<span> and other techniques such as brachytherapy<span>. In this review, we explore the use of brachytherapy and partial bladder fields of external beam radiation therapy in the treatment of MIBC.</span></span></span></span></p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"33 1","pages":"Pages 76-81"},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy\",\"authors\":\"Jenna M. Kahn ,&nbsp;Geert A.H.J. Smits ,&nbsp;Bernard J. Oosterveld ,&nbsp;Elzbieta M. van der Steen-Banasik\",\"doi\":\"10.1016/j.semradonc.2022.10.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Organ preservation for muscle-invasive </span>bladder<span> cancer (MIBC) may use trimodality therapy. This includes transurethral resection<span><span><span><span> followed by radiation therapy<span><span>. Radiosensitization has become one of the </span>standard of care<span> approaches for MIBC with high rates of local disease control and overall survival. The goal of organ preservation is to treat MIBC while preserving a well-functioning natural bladder. Debate remains over the best way to optimize radiation therapy in bladder cancer. In MIBC the role of </span></span></span>partial cystectomy has been utilized in smaller solitary tumors with adequate local control and good </span>urinary<span> function. As radiation therapy techniques improve and modernize, smaller radiation volumes to a partial bladder may play an increasing role as we utilize imaging techniques coupled with adaptive </span></span>radiation therapy planning<span> and other techniques such as brachytherapy<span>. In this review, we explore the use of brachytherapy and partial bladder fields of external beam radiation therapy in the treatment of MIBC.</span></span></span></span></p></div>\",\"PeriodicalId\":49542,\"journal\":{\"name\":\"Seminars in Radiation Oncology\",\"volume\":\"33 1\",\"pages\":\"Pages 76-81\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in Radiation Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1053429622000649\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1053429622000649","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

肌肉浸润性膀胱癌症(MIBC)的器官保存可采用三模态疗法。这包括经尿道电切术后进行放射治疗。放射增敏已成为MIBC的标准护理方法之一,具有较高的局部疾病控制率和总体生存率。器官保存的目标是治疗MIBC,同时保留功能良好的天然膀胱。关于优化膀胱癌症放射治疗的最佳方法仍存在争议。在MIBC中,膀胱部分切除术的作用已被用于较小的孤立性肿瘤,具有足够的局部控制和良好的尿功能。随着放射治疗技术的改进和现代化,当我们利用成像技术与自适应放射治疗计划和其他技术(如近距离放射治疗)相结合时,对部分膀胱的较小放射量可能会发挥越来越大的作用。在这篇综述中,我们探讨了近距离放射治疗和外束放射治疗膀胱部分野在MIBC治疗中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy

Organ preservation for muscle-invasive bladder cancer (MIBC) may use trimodality therapy. This includes transurethral resection followed by radiation therapy. Radiosensitization has become one of the standard of care approaches for MIBC with high rates of local disease control and overall survival. The goal of organ preservation is to treat MIBC while preserving a well-functioning natural bladder. Debate remains over the best way to optimize radiation therapy in bladder cancer. In MIBC the role of partial cystectomy has been utilized in smaller solitary tumors with adequate local control and good urinary function. As radiation therapy techniques improve and modernize, smaller radiation volumes to a partial bladder may play an increasing role as we utilize imaging techniques coupled with adaptive radiation therapy planning and other techniques such as brachytherapy. In this review, we explore the use of brachytherapy and partial bladder fields of external beam radiation therapy in the treatment of MIBC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.80
自引率
0.00%
发文量
48
审稿时长
>12 weeks
期刊介绍: Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
期刊最新文献
Radiation as an Immune Modulator: Where We Are With Modern Total Body Irradiation. Radiation for Multiple Myeloma in the Era of Novel Agents: Indications, Safety, and Dose Selection. Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma. Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship. Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1